Fibromyalgia News

Fibromyalgia is a spectrum or dimensional disorder, according to evidence from a recent study, in which researchers determined its prevalence in 2.1% of the general population in Germany.

An interdisciplinary treatment program for patients with fibromyalgia improved their quality of life, pain, physical function, anxiety and depression, and pain-coping strategies for up to 1 year after intervention, according to study results.

Therapies using the Rességuier method and Qigong improved pain, disability, quality of life, tenderness and anxiety in patients with fibromyalgia, according to study results.

Fibromyalgia is related to bipolar spectrum disorders, particularly the hypomania/overactivity component, according to study results.

Patients with fibromyalgia reported more sensory and nonsensory symptoms compared with patients with rheumatoid arthritis or osteoarthritis, according to study results.

New central acting drug use for treating patients with fibromyalgia has quadrupled during the last decade, but researchers were not convinced about the costly drugs’ clinical advantages, according to study results.

Patients with fibromyalgia have a high prevalence of alexithymia and psychological distress that, if evaluated, may help clinicians treat this population and improve their quality of life, according to study results.

Estimated hospitalization charges for fibromyalgia during a 9-year period in the United States totaled almost $1 billion, according to study results.

Although evidence indicated that childhood sexual abuse was related to the development of fibromyalgia, it was not attributable to depression, according to study results.

Dietary glutamate might have contributed to recurrent symptoms in some patients with fibromyalgia, according to study results.